EXACT SCIENCES HIGHLIGHTS THE OPPORTUNITY TO SEEK SCREENING WITH COLOGUARD® THROUGH TELEHEALTH

MAKING COLORECTAL CANCER SCREENING MORE ACCESSIBLE DURING UNPRECEDENTED TIMES MADISON, Wis. – April 2, 2020 – Exact Sciences Corp. (NASDAQ: EXAS) today announced it would be ...

Message from Chairman & CEO, Kevin Conroy

At Exact Sciences, we know that cancer doesn’t stop for anything. As we continue to monitor the Coronavirus (COVID-19) pandemic, our team remains steadfast in our commitment ...

Fight colorectal cancer receives grant from exact sciences to launch program aimed at reducing patient barriers to colorectal cancer screening

SPRINGFIELD, Mo. and MADISON, Wis. (Mar. 11, 2020) — Fight Colorectal Cancer (Fight CRC) announced today the launch of the Catalyst State-by-State Advocacy Program, with the ...

April 2, 2020

EXACT SCIENCES HIGHLIGHTS THE OPPORTUNITY TO SEEK SCREENING WITH COLOGUARD® THROUGH TELEHEALTH

March 15, 2020

Message from Chairman & CEO, Kevin Conroy

March 11, 2020

Fight colorectal cancer receives grant from exact sciences to launch program aimed at reducing patient barriers to colorectal cancer screening

December 12, 2019

New Evidence from Large Studies Highlights Value of Oncotype DX Breast Recurrence Score® to Guide Chemotherapy Treatment in Young Patients with Node-Negative or Node-Positive Early-Stage Breast Cancer

December 5, 2019

Dr. David Ahlquist, Co-Inventor of Cologuard, Named a Fellow of the National Academy of Inventors

November 8, 2019

Exact Sciences Completes Combination with Genomic Health, Creating Leading Global Cancer Diagnostics Company

November 8, 2019

Exact Sciences Presents Data on Blood-based Test for Detection of Hepatocellular Carcinoma, Earns FDA Breakthrough Device Designation

October 29, 2019

Exact Sciences Presents New Stool-based Colorectal Cancer Screening Performance Data, Initiates Prospective Screening Study

September 24, 2019

Multimedia

Videos

Photos

Digital newsroom

EXACT SCIENCES HIGHLIGHTS THE OPPORTUNITY TO SEEK SCREENING WITH COLOGUARD® THROUGH TELEHEALTH

Message from Chairman & CEO, Kevin Conroy

Fight colorectal cancer receives grant from exact sciences to launch program aimed at reducing patient barriers to colorectal cancer screening

EXACT SCIENCES HIGHLIGHTS THE OPPORTUNITY TO SEEK SCREENING WITH COLOGUARD® THROUGH TELEHEALTH

Message from Chairman & CEO, Kevin Conroy

Fight colorectal cancer receives grant from exact sciences to launch program aimed at reducing patient barriers to colorectal cancer screening

New Evidence from Large Studies Highlights Value of Oncotype DX Breast Recurrence Score® to Guide Chemotherapy Treatment in Young Patients with Node-Negative or Node-Positive Early-Stage Breast Cancer

Dr. David Ahlquist, Co-Inventor of Cologuard, Named a Fellow of the National Academy of Inventors

Exact Sciences Completes Combination with Genomic Health, Creating Leading Global Cancer Diagnostics Company

Exact Sciences Presents Data on Blood-based Test for Detection of Hepatocellular Carcinoma, Earns FDA Breakthrough Device Designation

Exact Sciences Presents New Stool-based Colorectal Cancer Screening Performance Data, Initiates Prospective Screening Study

PGA Tour Champions and Exact Sciences Announce Five-year Extension of Cologuard Classic

Cologuard® Gains FDA Approval for Use in Younger Americans, Ages 45 to 49

Exact Sciences Named One of the 2019 Best Workplaces for Women by Great Place to Work and Fortune

Cologuard® Helps More People Get Screened In A Cost-Effective Way

Multimedia

Quick links

Digital newsroom

EXACT SCIENCES HIGHLIGHTS THE OPPORTUNITY TO SEEK SCREENING WITH COLOGUARD® THROUGH TELEHEALTH

Message from Chairman & CEO, Kevin Conroy

Fight colorectal cancer receives grant from exact sciences to launch program aimed at reducing patient barriers to colorectal cancer screening

Multimedia

Quick links

Follow us on